Unichem Laboratories Ltd Share Price

Overview

Unichem Laboratories Ltd share price is currently ₹519.76, up by ₹17.04 (3.39%) from its previous closing price of ₹502.72. The share price has declined -2.52% over the past month and declined -12.79% over the past year. The stock's 52-week low and high are ₹276.52 and ₹677.21, respectively. Unichem Laboratories Ltd has a market capitalisation of ₹ 3,700.00 Cr. The share price was last updated on 25 Aug 2026, 03:50 PM IST.

Unichem Laboratories Ltd

UNICHEMLAB

₹0.00

₹17.04

3.39%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:50:10 pm IST

Market Data

Open Price

₹508.06

Prev. Close

₹502.72

₹497.65

Day Low

₹550.20

Day High

₹276.52

52 Week Low

₹677.21

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

22.01

Sector PE

42.03

PB Ratio

1.35

Sector PB

5.83

EPS

23.62

Dividend Yield

0.00

Today's Volume

819.498 K

5 Day Avg. Volume

218.253 K

PEG Ratio

0.26

Market Cap.

₹ 3,700.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
HDFC Small Cap Fund - Regular Plan - Growth	54.59 Lac	49.59 Lac (9.16%)
DSP Healthcare Fund - Regular Plan - Growth	11.11 Lac	11.24 Lac (1.25%)
Motilal Oswal BSE Healthcare ETF	548	559 (2.01%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth	280	300 (7.14%)
Motilal Oswal BSE 1000 Index Fund - Regular Plan - Growth	62	61 (1.61%)

Show all holdings

About Unichem Laboratories Ltd 👋

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.